IFNL3 and infection: Collectively these data suggest that patients with high baseline IP-10 levels (>150 pg/mL), particularly those with asymptomatic disease and/or an unfavourable IL28B genotype, should be prioritized for early antiviral therapy because they are unlikely to achieve spontaneous clearance but still have a high likelihood of SVR with treatment during the acute phase of infection (Figure 7).